Aripiprazole in treatment of borderline patients, part II: an 18-month follow-up
- Marius K. NickelAffiliated withClinic for Psychosomatic Medicine and Psychotherapy, Medical University of GrazUniversity Clinic for Psychiatry 1, PMU Email author
- , Thomas H. LoewAffiliated withDepartment of Psychosomatic Medicine, University Clinic
- , Francisco Pedrosa GilAffiliated withPsychosomatic Outpatient Clinic, University Medicine Clinic, LMU
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Only one controlled trial is known that employed aripiprazole for patients with borderline personality disorder (BPD). This 8-week trial found significant changes on most scales of the symptom checklist (SCL-90-R), Hamilton depression rating scale (HDRS), Hamilton anxiety rating scale (HARS), and on all scales of the state–trait anger expression inventory (STAXI).
Objectives, materials, and methods
To assess the long-term effectiveness of aripiprazole with multifaceted borderline symptomology, this 18-month follow-up observation with biannual testing was carried out with the same patients from the previous trial (treated with 15-mg aripiprazole daily, n = 26, 21 female and 5 male patients; previous placebo group, n = 26, 22 female and 4 male patients).
According to the intent-to-treat principle, significant changes on all scales of the SCL-90-R, HDRS, HARS, and STAXI were observed in the aripiprazole-treated subjects after 18 months.
Aripiprazole appears to be an effective and relatively safe agent in the long-term treatment of patients with BPD.
KeywordsBorderline personality disorder Aripiprazole Hamilton depression rating scale
- Aripiprazole in treatment of borderline patients, part II: an 18-month follow-up
Volume 191, Issue 4 , pp 1023-1026
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- Borderline personality disorder
- Hamilton depression rating scale
- Industry Sectors
- Author Affiliations
- 1. Clinic for Psychosomatic Medicine and Psychotherapy, Medical University of Graz, 8990, Bad Aussee, Austria
- 2. University Clinic for Psychiatry 1, PMU, Salzburg, Austria
- 3. Department of Psychosomatic Medicine, University Clinic, Regensburg, Germany
- 4. Psychosomatic Outpatient Clinic, University Medicine Clinic, LMU, Munich, Germany